Table 3.
Comparison of incidental MRI findings between genders in patients with obsessive-compulsive disorder
| Male (n = 22) N/% |
Female (n = 36) N/% |
χ2 | p | ||
|---|---|---|---|---|---|
| Atrophy | Generalized Cerebral | 4 / 18.2 | 5 / 13.9 | 0.192 | 0.661 |
| Fazekas | Grade 1 | 4 / 18.2 | 6 / 16.7 | 0.955 | 0.749 N/A |
| Grade 2 | 0 / 0 | 2 / 5.6 | |||
| Cavum Septum Pellucidum | 2 / 9.1 | 3 / 8.3 | 2.812 | 1.000* | |
| Cavum Vergae | 3 / 13.6 | 0 / 0 | N/A | ||
| Cavum Veli Interpositi | 1 / 4.5 | 11 / 30.6 | 5.630 | 0.021* | |
| Ethmoidal Thickening | 13 / 59.1 | 16 / 44.4 | 1.172 | 0.279 | |
| Maxillary Thickening | 2 / 9.1 | 5 / 13.9 | 0.698* | ||
| Sphenoid Thickening | 2 / 9.1 | 1 / 2.8 | 0.551* | ||
| Frontal Thickening | 1 / 4.5 | 0 / 0 | 0.379* | ||
| Retention Cyst | 7 / 31.8 | 4 / 11.1 | 3.810 | 0.051 | |
| Septal Deviation | 20 / 42.5 | 18 / 36 | 2.336 | 0.264 | |
| Adenoid Hypertrophy | 4 / 18.2 | 6 / 16.7 | 0.022 | 0.882 | |
| Nonspesific Gliotic Foci | 2 / 9.1 | 2 / 5.6 | 0.266 | 0.630* | |
| Demyelination Plaque | 1 / 4.5 | 0 / 0 | 1.000* | ||
| Mastoiditis | 1 / 2.8 | 1 / 4.5 | 0.128 | 1.000* | |
| Partial Empty Sella | 0 / 0 | 2 / 5.6 | 1.000* | ||
| Pituitary Macroadenoma | 1 / 4.5 | 0 / 0 | 1.000* | ||
| Neuroglial Cyst | 1 / 4.5 | 0 / 0 | 1.000* | ||
| Parotid Liposubstitution | 0 / 0 | 1 / 2.8 | 1.000* | ||
| Arachnoid Cyst | 2 / 9.1 | 2 / 5.6 | 0.266 | 0.630* |
Chi-square test was used. p values < 0.05 being considered significant
*Fischer’s exact test